TDP-43, along with other disease-related RNA-binding proteins such as fused in sarcoma (FUS), promotes gene silencing by interacting with miRNA and mRNA targets, a mechanism that may contribute to degeneration in ALS/FTD [14,15]. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.